Role of FKBP12/12.6 in Endothelial Function
FKBP12/12.6 在内皮功能中的作用
基本信息
- 批准号:7479587
- 负责人:
- 金额:$ 21.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:2-aminoethoxydiphenyl borateAcuteAdverse effectsAffectAgonistBindingBiological AssayBlood PressureBlood VesselsCalcineurinCalciumCardiacCardiovascular DiseasesCardiovascular systemCaveolaeCell membraneCharacteristicsCouplingDataDilatorDoseElevationEndothelial CellsEndotheliumEnzymesExcisionExhibitsFK506FKBP1B geneFluorescenceFunctional disorderFutureGeneticGoalsGraft RejectionHigh Blood PressureHomeostasisHypertensionITPR1 geneImmune systemImmunoblottingImmunosuppressive AgentsIn VitroIncidenceKnockout MiceLaboratoriesLinkLocationMeasurementMeasuresMediatingModelingMolecularMusMuscle FibersMutant Strains MiceMutationNitric OxideNitric Oxide SynthaseOrganOrgan TransplantationPathway interactionsPharmaceutical PreparationsPhosphorylationPhosphotransferasesProductionProtein Kinase CProteinsRelative (related person)ResearchResearch PersonnelRoleRyanodineRyanodine Receptor Calcium Release ChannelSignal TransductionSignal Transduction PathwaySirolimusSiteSourceTacrolimus Binding Protein 1ATacrolimus Binding ProteinsTailTechniquesTelemetryTestingTherapeuticTransplant RecipientsTransplantationWorkblood pressure regulationextracellularhuman FRAP1 proteinhuman NOS3 proteinin vivoprogramsrelease of sequestered calcium ion into cytoplasm
项目摘要
DESCRIPTION (provided by applicant): Immunosuppressive drugs reduce the incidence of organ rejection following transplantation, however these drugs can cause endothelial dysfunction and hypertension. Our long-term goal is to elucidate the mechanisms by which the immunosuppressive drugs rapamycin and FK506 decrease nitric oxide (NO) and increase blood pressure so that future drugs can be developed that do not promote hypertension and cardiovascular disease. We hypothesize that these effects arise from removal of FKBP12/12.6 from intracellular calcium release channels resulting in increased basal endothelial cell calcium levels and phosphorylation of endothelial NO synthase (eNOS). To test this hypothesis we will: 1) Determine the effects of FKBP12/12.6 depletion on intracellular calcium homeostasis, 2) Determine the role of cPKC in eNOS phosphorylation, NO production, and blood pressure elevation following alterations of FKBP12/12.6, and 3) Assess the role of FKBP12/12.6 in endothelial function and blood pressure regulation. We will use a combination of pharmacologic and/or genetic perturbations of FKBP12/12.6 and measure the effects on blood pressure, endothelium-dependent dilation, NO production, and eNOS and PKC expression and phosphorylation. We will also measure how FKBP12/12.6 depletion in endothelial cells alters intracellular calcium homeostasis including changes in the magnitude, duration, and location of intracellular calcium mobilization. Drugs that suppress the immune system are extremely important following organ transplantation, however these drugs can cause high blood pressure. Our research will use various genetically altered mice and techniques to understand the mechanisms of how this happens in hopes of developing future immunosuppressive drugs that will not have negative cardiovascular side effects.
描述(由申请人提供):免疫抑制药物可降低移植后器官排斥反应的发生率,但这些药物可导致内皮功能障碍和高血压。我们的长期目标是阐明免疫抑制药物雷帕霉素和FK 506降低一氧化氮(NO)和升高血压的机制,以便将来可以开发不促进高血压和心血管疾病的药物。我们假设这些作用是由于从细胞内钙释放通道中去除FKBP 12/12.6导致基础内皮细胞钙水平增加和内皮NO合酶(eNOS)磷酸化。为了验证这一假设,我们将:1)确定FKBP 12/12.6耗竭对细胞内钙稳态的影响,2)确定FKBP 12/12.6改变后cPKC在eNOS磷酸化、NO产生和血压升高中的作用,3)评估FKBP 12/12.6在内皮功能和血压调节中的作用。我们将使用FKBP 12/12.6的药理学和/或遗传学扰动的组合,并测量对血压、内皮依赖性舒张、NO产生以及eNOS和PKC表达和磷酸化的影响。我们还将测量内皮细胞中FKBP 12/12.6耗竭如何改变细胞内钙稳态,包括细胞内钙动员的幅度、持续时间和位置的变化。抑制免疫系统的药物在器官移植后非常重要,但这些药物可能导致高血压。我们的研究将使用各种基因改变的小鼠和技术来了解这种情况如何发生的机制,希望开发出未来不会产生负面心血管副作用的免疫抑制药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRETT M MITCHELL其他文献
BRETT M MITCHELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRETT M MITCHELL', 18)}}的其他基金
Texas A&M College of Medicine Developing and Readying Underrepresented Minority Researchers (DRUMR) Summer Research Program
德克萨斯A
- 批准号:
10680395 - 财政年份:2020
- 资助金额:
$ 21.83万 - 项目类别:
Texas A&M College of Medicine Developing and Readying Underrepresented Minority Researchers (DRUMR) Summer Research Program
德克萨斯A
- 批准号:
10447171 - 财政年份:2020
- 资助金额:
$ 21.83万 - 项目类别:
Texas A&M College of Medicine Developing and Readying Underrepresented Minority Researchers (DRUMR) Summer Research Program
德克萨斯A
- 批准号:
10261491 - 财政年份:2020
- 资助金额:
$ 21.83万 - 项目类别:
Texas A&M College of Medicine Developing and Readying Underrepresented Minority Researchers (DRUMR) Summer Research Program
德克萨斯A
- 批准号:
10090921 - 财政年份:2020
- 资助金额:
$ 21.83万 - 项目类别:
Role of Renal Lymphatics in Blood Pressure Regulation
肾淋巴管在血压调节中的作用
- 批准号:
10337228 - 财政年份:2019
- 资助金额:
$ 21.83万 - 项目类别:
Role of FKBP12/12.6 in Endothelial Function
FKBP12/12.6 在内皮功能中的作用
- 批准号:
7839416 - 财政年份:2009
- 资助金额:
$ 21.83万 - 项目类别:
Role of FKBP12/12.6 in Endothelial Function
FKBP12/12.6 在内皮功能中的作用
- 批准号:
7664949 - 财政年份:2007
- 资助金额:
$ 21.83万 - 项目类别:
Role of FKBP12/12.6 in Endothelial Function
FKBP12/12.6 在内皮功能中的作用
- 批准号:
7910682 - 财政年份:2007
- 资助金额:
$ 21.83万 - 项目类别:
Role of FKBP12/12.6 in Endothelial Function
FKBP12/12.6 在内皮功能中的作用
- 批准号:
7320563 - 财政年份:2007
- 资助金额:
$ 21.83万 - 项目类别:
Role of Immune Cells in Immunosuppressive Drug-Induced Hypertension
免疫细胞在免疫抑制药物诱发的高血压中的作用
- 批准号:
8732802 - 财政年份:2006
- 资助金额:
$ 21.83万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 21.83万 - 项目类别:
Operating Grants